Horizon Discovery

📍 Cambridge, United Kingdom🗓 Founded 2005👥 129 employees💰 Last funded Apr 2012
Biotechnology Research🌐 horizondiscovery.com
Website LinkedIn
Horizon Discovery, formerly of PerkinElmer, and now part of the Revvity family, drives the application of gene editing and gene modulation to enable world-leading academic institutes, pharmaceutical and biotechnology companies, as well as clinical diagnostic laboratories, to identify the genetic drivers behind human disease, develop and validate diagnostic workflows, and deliver new therapies for precision medicine. With more than a decade of experience in the engineering of cell lines, Horizon offers innovative tools and services based upon the ability to modulate, or permanently alter, the function of almost any gene in human and other mammalian cell lines. Horizon is headquartered in Cambridge, UK with offices in USA and Japan.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2005
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
2
Frequently asked questions
Who invested in Horizon Discovery?
Horizon Discovery has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Horizon Discovery last raise funding?
The most recent investment in Horizon Discovery recorded on gritt.io was in April 2012.
When was Horizon Discovery founded?
Horizon Discovery was founded in 2005.
What industry is Horizon Discovery in?
Horizon Discovery operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Horizon Discovery based?
Horizon Discovery is headquartered in Cambridge, United Kingdom.